Xinyan Li

5PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 30, 2026
Ursodeoxycholic acid enhances cancer radioimmunotherapy by releasing a human-biased FXR-TRIM22-STAT1 immune brake.

|Nov 03, 2025
Targeting the ATM-TGS1-BRCA1 Axis Overcomes Genotoxic Therapy Resistance in Pancreatic Adenocarcinoma.

Changying Li, Xuran Zhao, Xinyan Li

|Oct 10, 2025
Targeting the ATM-TRMT10A-BRCA1 axis confers synthetic lethality to PARP inhibition in metastatic castration-resistant prostate cancer.

Ying Yang, Qiang Liu, Xinyan Li

|Sep 10, 2020
Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer.

Xinyan Li, Litong Yao, Mozhi Wang

|Jan 04, 2020
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy.

Xinyan Li, Mozhi Wang, Mengshen Wang

Pageof 1

Frequent Collaborators

3 joint publications

Zhenkun Lou

3 joint publications

Somaira Nowsheen

2 joint publications

Mozhi Wang

2 joint publications

Mengshen Wang